KNSA vs UNH: fair value comparison
Kiniksa Pharmaceuticals International, plc and UnitedHealth Group Incorporated · Updated 2026-08-31
KNSA currently screens as fairly valued while UNH screens as undervalued. Within Healthcare, UNH currently sits closer to the top of our discount ranking. KNSA carries the stronger quality grade.
| KNSA | UNH | |
|---|---|---|
| Verdict | Fairly valued | Undervalued |
| Last price | $73.41 | $392.95 |
| 12-month range | $34.28–$73.41 | $273.98–$415.36 |
| Sector rank | #58 of 113 Healthcare | #53 of 113 Healthcare |
| Quality grade | D | F |
| Leverage | Low | Moderate |
| Margin trend | — | Contracting |
| Revenue growth | — | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | — | Undervalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: KNSA fair value analysis · UNH fair value analysis